Protein could be target for MLL-rearranged AMLJuly 12, 2018Leukemia, Myelodysplasia, TransplantationAML
Identifying patients with a high risk of AMLJuly 11, 2018Leukemia, Myelodysplasia, TransplantationAML
A new use for ibrutinib?July 10, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
FDA lifts hold on trial of MYC inhibitorJuly 2, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Quizartinib can prolong OS in rel/ref, FLT3-ITD AMLJune 18, 2018Leukemia, Myelodysplasia, TransplantationAML
Ivosidenib active in R/R IDH1-mutated AML patientsJune 14, 2018Leukemia, Myelodysplasia, TransplantationAML
Two agents could take AML therapy in new directionsJune 7, 2018Leukemia, Myelodysplasia, TransplantationAML
FDA grants priority review to gilteritinib for R/R AMLMay 30, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
CAR T-cell therapy bridges to HSCT in AML patientMay 9, 2018Leukemia, Myelodysplasia, TransplantationTransplantationAML
